Human growth hormone treatment for Prader-Willi syndrome in adolescent and adult patients: clinical evidence, safety, and guidelines
The purpose of this report is to review the clinical effectiveness of human growth hormone (GH) treatment for Prader-Willi syndrome (PWS) in adolescent and adult patients and the evidence based guidelines for the use of GH for treating adolescents and adults with PWS. This report is an update of a p...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottawa, Ont.]
CADTH Rapid Response Service
[2015], 2015
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this report is to review the clinical effectiveness of human growth hormone (GH) treatment for Prader-Willi syndrome (PWS) in adolescent and adult patients and the evidence based guidelines for the use of GH for treating adolescents and adults with PWS. This report is an update of a previous CADTH Rapid Response Report which included one meta-analysis, two RCTs and 10 non-randomized studies and reported that GH therapy in patients with PWS, had multiple beneficial effects on body composition and growth and a few negative effects |
|---|---|
| Item Description: | Title from caption title. - "06 November 2015." |
| Physical Description: | 1 PDF file (42 pages) illustration |